No idea in terms of how much market share they can capture. The...

No idea in terms of how much market share they can capture. The Solgen example gives some colour of what is possible.

However, all these products are "through the skin" delivery (i.e. Acrux's expertise) which is a niche market and hopefully few competitors when launched.

One query I have is regarding the generic competition for their Jublia submission. It looked like there were a lot of competitors "first to file" but were those competitors also proposing the generic as "through the skin" application? If the answer is no, then we have a good advantage over the other competitors!